Abstract
Photodynamic therapy is generally carried out using a laser, usually a dye laser with the wavelength tuned to suit the particular sensitizer. The availability of broad-band sources for use in photodynamic therapy is challenging the role of the laser, since the non-laser sources are more portable and less expensive. Also, the wavelengths utilized may easily be changed by optical filtering. However, the use of a broad-band source introduces serious problems with dosimetry. The concept of the ‘total effective fluence’ takes account of the incident spectral irradiance from the light source, optical transmission through tissue (preferably including backscatter), and absorption by the sensitizer. Application of the concept to various light sources demonstrates the potential value of this simple concept.
Similar content being viewed by others
References
Shopova M, Stoichkov N, Milev A et al. Photodynamic therapy of experimental tumours with Zn(II)-phthalocyanine and pulsed laser irradiation.Lasers Med Sci 1995,10:43–6
Moghisi K, Dixon K, Hudson E, Stringer M. Photodynamic therapy of oesophageal cancer.Lasers Med Sci 1995,10:67–71
Uchibaysi T, Koshida K, Kunimi K, Hisazumi H. Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder.Br J Cancer 1995,71:625–8
Purkiss SF, Grahn MF, Abulafi AM et al. Multiple fibre interstitial photodynamic therapy of patients with colorectal liver metastases.Lasers Med Sci 1994,9:27–35
Anholt H, Peng Q, Moan J. Uptake, localization and effect of laser treatment on CaD2 tumours sensitized with aluminium phthalocyanine tetrasulfonate (AlPcS4).Lasers Med Sci 1994,9:111–8
Berenbaum MC, Bonnett R, Chevretton EB et al. Selectivity of meso-tetra (hydroxyphenyl) porphyrins and chlorins and of photofrin II in causing photodamage in tumour, skin, muscle and bladder. The concept of cost-benefit in analysing the results.Lasers Med Sci 1993,8:235–43
McKenzie AL, Carruth JAS. A comparison of gold vapour and dye lasers for photodynamic therapy.Lasers Med Sci 1986,1:117–20
Barr H, Boulos PB, MacRobert AJ et al. Comparison of lasers for photodynamic therapy with a phthalocyanine photosensitizer.Lasers Med Sci 1989,4:7–12
Stamp JM, Fowler GJS, Devonshire R, Williams JL. The use of photodynamic therapy (PDT) for the treatment of superficial tumours on the bladder wall.Lasers Med Sci 1990,5:5–12
van Best JA, Schuitmaker HJ, Dubbelman TMAR et al. Near infra-red diode laser for photodynamic therapy using bacteriochlorin a.Lasers Med Sci 1993,8:157–62
Doiron DR, Papworth B, Severson D et al. A high efficiency, multi-use laser system for photodynamic therapy (Abs).Lasers Med Sci 1992,7:212
Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experiences.J Photochem Photobiol B: Biology 1990,6:143–8
Morton CA, Whitehurst C, Moseley H et al. Development of an alternative light source to lasers for photodynamic therapy: 3. Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer.Lasers Med Sci 1995,10:165–71
Whitehurst C, Byrne K, Moore JV. Development of an alternative light source to lasers for photodynamic therapy: 1. Comparative in vitro dose response characteristics.Lasers Med Sci 1993,8:259–67
Whitehurst C, Humphries JD, Moore JV. Development of an alternative light source to lasers for photodynamic therapy: 2. Comparative in vivo tumour response characteristics.Lasers Med Sci 1995,10:121–6
Szeimies R-M, Hein R, Baumler W et al. A possible new incoherent lamp for photodynamic treatment of superficial skin lesions.Acta Derm Venereol (Stockh) 1994,74:117–9
Daniels F. Optics of the skin as related to ultraviolet radiation. In: Urbach F (ed)The Biologic Effects of Ultraviolet Radiation with Emphasis on the Skin. Oxford: Pergamon, 1969:151–7
Wan S, Anderson RR, Parrish JA. Analytical modelling for the optical properties of the skin with in vitro and in vivo applications.Photochem Photobiol 1981,34:493–9
Anderson RR, Parrish JA. The optics of human skin.J Invest Dermatol 1981,77:13–8
van Gemert MJC, Welch AJ, Miller ID, Tan OT. Can physical modelling lead to an optimal laser treatment strategy for port-wine stains? In: Wolbarsht ML (ed)Laser Applications in Medicine and Biology, Vol 5. New York: Plenum, 1989:Chap 5
Moan J, Sommer S. Fluorescence and absorption properties of the components of hematoporphyrin derivative.Photobiochem Photobiophys 1981,3:93–103
Andreoni A, Cubeddu R. Photophysical properties of Photofrin II in different solvents.Chem Phys Lett 1984,108:141–4
Bottiroli G, Docchio F, Frietas I et al. Spectroscopic studies of haematoporphyrin-derivative in culture medium.Chem Biol Interact 1984,50:153–7
Kessel D. In vivo fluorescence of tumour after treatment with derivatives of haematoporphyrin.Photochem Photobiol 1986,44:107–8
Ramponi R, Sacchi CA, Cubeddu R. Present status of research on haematoporphyrin derivatives and their photophysical properties. In: Wolbarsht ML (ed)Laser Applications in Medicine and Biology, Vol 5. New York: Plenum, 1989:Chap 2
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moseley, H. Total effective fluence: a useful concept in photodynamic therapy. Laser Med Sci 11, 139–143 (1996). https://doi.org/10.1007/BF02133211
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02133211